Radioimmunoassay for leukotriene B4

Area of Science:

• Immunology
• Biochemistry
• Analytical Chemistry

Background:

• Leukotriene B(4) (LTB(4)) is a potent lipid mediator involved in inflammatory and immune responses.
• Accurate quantification of LTB(4) is essential for studying its role in various physiological and pathological conditions.
• Existing methods for LTB(4) detection may lack the required sensitivity or specificity for complex biological matrices.

Purpose of the Study:

• To develop and validate a sensitive and specific radioimmunoassay (RIA) for the quantification of leukotriene B(4) (LTB(4)).
• To assess the specificity of the developed RIA against related lipid mediators and isomers.
• To demonstrate the applicability of the RIA for measuring LTB(4) produced by activated immune cells.

Main Methods:

• Production of rabbit polyclonal antibodies against leukotriene B(4) (LTB(4)) conjugated to bovine serum albumin.
• Characterization of antibody affinity and specificity using radioligand binding assays with radiolabeled LTB(4) and various competitors.
• Analysis of LTB(4) production by calcium ionophore-activated rat serosal mast cells and human neutrophils using reversed-phase High-Performance Liquid Chromatography (HPLC) coupled with the developed RIA.

Main Results:

• The developed RIA exhibited a high association constant (K(a) = 3.2 x 10(9) M(-1)) for [14,15-(3)H]LTB(4).
• The assay demonstrated excellent specificity, with minimal cross-reactivity to sulfidopeptide leukotrienes (LTC(4), LTD(4)), LTB(4) isomers, 5-HETE, and prostaglandins.
• Immunoreactive LTB(4) produced by activated rat mast cells (4.6 ng per 10(6) cells) and human neutrophils coeluted with synthetic LTB(4) upon HPLC analysis.
• Direct RIA of cell supernatants after HPLC achieved a 54% recovery, validating its applicability to unfractionated biological fluids.

Conclusions:

• A sensitive and specific radioimmunoassay for leukotriene B(4) (LTB(4)) has been successfully developed.
• The RIA is highly specific for LTB(4), distinguishing it from related lipid mediators.
• The assay is directly applicable to unfractionated biological fluids, enabling accurate quantification of LTB(4) produced by activated immune cells.